MEDPlus

12/10/2025

C'est elle qui a réalisé la toute première greffe de moelle osseuse au Québec.

Entretien avec cette lauréate des premiers Prix Châtelaine : https://fr.chatelaine.com/societe/entrevues/yvette-bonny-prix-chatelaine/

07/10/2025

Starting next year, New York will become the first state in the nation to require that private insurance companies cover scalp cooling for chemotherapy patients.

Scalp cooling, a treatment that helps preserve hair during chemotherapy, is pricey — the National Cancer Institute cites an average cost between $1,500 and $5,000 per patient. It is often not covered by insurance.

Cold capping works by lowering the temperature of the scalp before and during chemotherapy to restrict blood flow to hair follicles and reduce the amount of chemo that reaches them.

Cooling also slows down the activity of the hair follicle cells, making them less vulnerable to damage from chemotherapy drugs.

Read more: https://abcnews.visitlink.me/dEhQVd

06/10/2025

03/10/2025

Scientists have uncovered new evidence that a common hormone, prolactin, may play a bigger role in breast cancer than previously thought. Known for helping women produce milk during pregnancy, prolactin is now linked to more aggressive breast cancers in two major studies.

Researchers identified a specific version of the prolactin receptor that can turn normal breast cells cancerous when paired with another receptor. Data from tumor samples showed this receptor is found at higher levels in triple-negative breast cancers, a hard-to-treat form of the disease.

The good news: lab tests using a drug called an HDAC6 inhibitor were able to stop breast cancer growth by blocking prolactin-driven signals. The drug is still experimental and not yet approved for breast cancer treatment, but these findings offer hope for future targeted therapies that could save lives.

While more research and clinical trials are needed, this study highlights a surprising connection between a hormone most women naturally produce and one of the deadliest forms of breast cancer.

03/10/2025

02/10/2025

01/10/2025

30/09/2025

28/09/2025

Stanford researchers have achieved a medical breakthrough that could change the future of cancer treatment. A newly designed lab-made molecule has shown the ability to wipe out some of the deadliest cancers, including aggressive breast and pancreatic tumors, with just three intravenous treatments. Unlike chemotherapy or radiation, which damage both healthy and cancerous cells, this molecule works with surgical precision — destroying tumors while leaving surrounding tissue largely unharmed. The results from preclinical trials are nothing short of extraordinary, with tumors shrinking or disappearing at an unprecedented rate.

What makes this discovery even more promising is its potential to replace harsh, toxic therapies that take a heavy toll on patients. Instead of months of debilitating treatments, patients could one day undergo just a few sessions with minimal side effects. Scientists believe this innovation could mark the beginning of a new era in oncology, where cancers once deemed nearly untreatable might finally have a clear path to defeat. Hope for millions of patients worldwide just took a powerful leap forward.

27/09/2025

08/03/2025